Skip to main content
. 2017 Oct 4;35(32):3706–3713. doi: 10.1200/JCO.2017.73.3238

Fig 2.

Fig 2.

Kaplan-Meier estimate of overall survival (OS) by dichotomized enhancer of zeste homolog 2 (EZH2) expression in patients stratified by Mayo stage, size, grade, and necrosis (SSIGN) scores. (A) low-risk, (B) intermediate-risk, and (C) high-risk scores.